journal article·2024-02-23Open access

Quantitative Analysis of Macrophage Uptake and Retention of Fluorescent Organosilica Nanoparticles: Implications for Nanoparticle Delivery and Therapeutics

Hung-Chang Chou, Shih-Jiuan Chiu, Teh-Min Hu

ACS Applied Nano Materials· Volume 7· Issue 4

Abstract

High Resolution Image Download MS PowerPoint Slide This study investigates the uptake and retention of stable fluorescent organosilica nanoparticles by macrophages, which play a vital role in scavenging environmental nanoparticles and nanomedicines within the body. We used rhodamine 6G-loaded fluorescent organosilica nanoparticles (SiNP-R6G) synthesized from a thiol-functionalized organosilane precursor. Our primary objective was to establish a quantitative relationship between fluorescent measurements and nanoparticle tracking analysis, enabling the precise “counting” of nanoparticles taken up by macrophages under kinetic measurement conditions. Our kinetic study demonstrated a concentration-dependent, saturable internalization of nanoparticles in a model macrophage (RAW 264.7 cells), with a maximum uptake rate ( V max ) of 7.9 × 10 4 nanoparticles per hour per cell. The estimated number concentration of nanoparticles for half-maximum uptake was approximately 0.8 trillion nanoparticles per milliliter, and a significant portion (∼80%) of internalized SiNP-R6G remained entrapped within the cells for 48 h, indicating the sustained particle retention capacity of macrophages. Our data further demonstrate that the internalized nanoparticles occupy more than 10% of the total cell volume, without inducing cytotoxic effects. This heightened capacity for nanoparticle uptake is attributed to intracellular vesicles capable of accommodating up to 50 densely packed, yet nonaggregated, nanoparticles within a single vesicle. In summary, our study underscores the effective development of a methodology for precise “counting” of cellular nanoparticle uptake in macrophages, providing valuable insights into the kinetics and retention capabilities of macrophages for nanoparticle-based drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan

Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan

Department of Pharmacy and Master Program, Tajen University, Pingtung 90741, Taiwan

Funding

National Science and Technology Council

References (68)

Show source-provided references
1. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
2. 10.1016/j.addr.2022.11423810.1016/j.addr.2022.114238 ↗
3. 10.1016/j.nantod.2015.06.00610.1016/j.nantod.2015.06.006 ↗
4. 10.1038/s41565-020-0759-510.1038/s41565-020-0759-5 ↗
5. 10.1002/smll.20090000510.1002/smll.200900005 ↗
6. 10.1021/nn100561e10.1021/nn100561e ↗
7. 10.1016/j.jconrel.2011.02.01710.1016/j.jconrel.2011.02.017 ↗
8. 10.1016/j.msec.2017.02.02810.1016/j.msec.2017.02.028 ↗
9. 10.1021/acsnano.0c0509710.1021/acsnano.0c05097 ↗
10. 10.1016/j.micromeso.2020.11059310.1016/j.micromeso.2020.110593 ↗
11. 10.1016/j.colsurfb.2020.11152710.1016/j.colsurfb.2020.111527 ↗
12. 10.1021/acs.molpharmaceut.8b0021310.1021/acs.molpharmaceut.8b00213 ↗
13. 10.1039/D0CS01127D10.1039/D0CS01127D ↗
14. 10.1021/acsami.0c1234110.1021/acsami.0c12341 ↗
15. 10.1016/j.taap.2008.06.00910.1016/j.taap.2008.06.009 ↗
16. 10.1002/anie.20190630310.1002/anie.201906303 ↗
17. 10.1016/j.biomaterials.2012.03.02910.1016/j.biomaterials.2012.03.029 ↗
18. 10.1021/acsnano.9b0160410.1021/acsnano.9b01604 ↗
19. 10.1021/nn400243d10.1021/nn400243d ↗
20. 10.1002/anie.20210173010.1002/anie.202101730 ↗
21. 10.1039/D1NR04690J10.1039/D1NR04690J ↗
22. 10.1002/smll.20190652310.1002/smll.201906523 ↗
23. 10.1038/nnano.2010.27710.1038/nnano.2010.277 ↗
24. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
25. 10.1021/acs.molpharmaceut.8b0127410.1021/acs.molpharmaceut.8b01274 ↗
26. 10.1007/s11356-012-1436-510.1007/s11356-012-1436-5 ↗
27. 10.1186/s12951-022-01670-910.1186/s12951-022-01670-9 ↗
28. 10.1021/ja208433810.1021/ja2084338 ↗
29. 10.1016/j.biomaterials.2015.02.07010.1016/j.biomaterials.2015.02.070 ↗
30. 10.1016/j.biomaterials.2010.08.11110.1016/j.biomaterials.2010.08.111 ↗
31. 10.1039/C6NR04042J10.1039/C6NR04042J ↗
32. 10.1039/D0NA00716A10.1039/D0NA00716A ↗
33. 10.1016/j.jcis.2020.11.07610.1016/j.jcis.2020.11.076 ↗
34. 10.1038/s41467-019-10112-410.1038/s41467-019-10112-4 ↗
35. 10.1039/D0NA00774A10.1039/D0NA00774A ↗
36. 10.3390/ijms23241566410.3390/ijms232415664 ↗
37. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
38. 10.2147/IJN.S14206010.2147/IJN.S142060 ↗
39. 10.2217/nnm.11.2710.2217/nnm.11.27 ↗
40. 10.1002/smll.20160128210.1002/smll.201601282 ↗
41. 10.1021/acsami.7b0347910.1021/acsami.7b03479 ↗
42. 10.1021/acsnano.1c1157810.1021/acsnano.1c11578 ↗
43. 10.1021/jacsau.2c0024710.1021/jacsau.2c00247 ↗
44. 10.1016/j.jconrel.2021.11.01610.1016/j.jconrel.2021.11.016 ↗
45. 10.1038/s41563-020-0755-z10.1038/s41563-020-0755-z ↗
46. 10.1039/D1NR00901J10.1039/D1NR00901J ↗
47. 10.1039/C7TB02233F10.1039/C7TB02233F ↗
48. 10.1021/acsomega.1c0487710.1021/acsomega.1c04877 ↗
49. 10.1021/la404821510.1021/la4048215 ↗
50. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
51. 10.1016/0272-0590(88)90284-910.1016/0272-0590(88)90284-9 ↗
52. 10.1289/ehp.102-156725210.1289/ehp.102-1567252 ↗
53. 10.1016/S0927-7765(02)00042-510.1016/S0927-7765(02)00042-5 ↗
54. 10.1021/acsabm.0c0025110.1021/acsabm.0c00251 ↗
55. 10.1021/acsnano.6b0005310.1021/acsnano.6b00053 ↗
56. 10.1021/nn501668a10.1021/nn501668a ↗
57. 10.1021/nl052396o10.1021/nl052396o ↗
58. 10.1021/nl070363y10.1021/nl070363y ↗
59. 10.1002/adma.20080139310.1002/adma.200801393 ↗
60. 10.1016/j.mtcomm.2020.10169210.1016/j.mtcomm.2020.101692 ↗
61. 10.1021/acs.analchem.9b0045410.1021/acs.analchem.9b00454 ↗
62. 10.1039/D0AY00170H10.1039/D0AY00170H ↗
63. 10.1115/1.403712410.1115/1.4037124 ↗
64. 10.1007/s11051-017-3966-810.1007/s11051-017-3966-8 ↗
65. 10.1038/s41598-019-38915-x10.1038/s41598-019-38915-x ↗
66. 10.1016/j.trac.2011.01.00510.1016/j.trac.2011.01.005 ↗
68. 10.1016/j.fbp.2021.03.01310.1016/j.fbp.2021.03.013 ↗